US stock · US markets · public data

BDX

Becton Dickinson & Co · Healthcare

Reference price$188.66Updated according to the public source
P/E43.87
P/B2.10
ROE6.61%
DY 12M2.22%
Net margin—
Net debt/equity—
Market capUS$ 51.4 B
Volume (shares)1,057,529
SectorHealthcare
Overview

About BDX

Demonstrações públicas consolidadas + SEC Company Facts

Becton Dickinson & Co (BDX) is a stock traded in US markets in the Healthcare sector. Revenue (FY2025): US$ 21.8 B. Net income (FY2025): US$ 1.68 B. Operating cash flow (FY2025): US$ 3.43 B.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: FY2025.

Distributions

Dividends and distributions · last 12 records

public data
12/22
03/23
06/23
12/23
03/24
06/24
12/24
03/25
06/25
12/25
03/26
06/26
Income in shown records$11.85
DY 12M2.22%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$1.05
Period ending 2026-03-31Dividendo declarado$1.05
Period ending 2025-12-31Dividendo declarado$1.05
Period ending 2025-06-30Dividendo declarado$1.04
Period ending 2025-03-31Dividendo declarado$1.04
Period ending 2024-12-31Dividendo declarado$1.04

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Reported dividends per share · FY2025: $4.16. This fiscal-year total is separate from the quarterly records and is not a trailing 12-month yield.

Financials

Income statement, balance sheet and cash flow

Available

Latest fiscal period: FY2025 (2024-10-01 – 2025-09-30).

Income statement

Account2022202320242025
Revenue$18,870,000,000.00$19,372,000,000.00$20,178,000,000.00$21,840,000,000.00
Gross Profit————
Operating Income$2,282,000,000.00$2,111,000,000.00$2,397,000,000.00$2,579,000,000.00
Net Income$1,779,000,000.00$1,484,000,000.00$1,705,000,000.00$1,678,000,000.00
EPS Diluted$5.88 / share$4.94 / share$5.86 / share$5.82 / share

Balance sheet

Account2022202320242025
Total Assets$52,934,000,000.00$52,780,000,000.00$57,286,000,000.00$55,325,000,000.00
Total Equity$25,282,000,000.00$25,796,000,000.00$25,890,000,000.00$25,390,000,000.00
Long-term Debt$13,886,000,000.00$14,738,000,000.00$17,940,000,000.00$17,621,000,000.00
Current Debt————
Shares Outstanding364,639,901 shares370,594,401 shares370,594,401 shares370,594,401 shares
Cash & Investments$1,014,000,000.00$1,424,000,000.00$2,162,000,000.00$649,000,000.00
Dívida Líquida————

Cash flow

Account2022202320242025
Operating Cash Flow$2,471,000,000.00$2,990,000,000.00$3,844,000,000.00$3,430,000,000.00
Capital Expenditures$973,000,000.00$874,000,000.00$725,000,000.00$760,000,000.00
Dividends Paid$1,082,000,000.00$1,114,000,000.00$1,100,000,000.00$1,196,000,000.00
Free Cash Flow$1,498,000,000.00$2,116,000,000.00$3,119,000,000.00$2,670,000,000.00
FAQ

Frequently asked questions

What is the price of BDX?

The reference price available for BDX is $188.66.

What is the P/E of BDX?

The P/E ratio of BDX is 43.87. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of BDX?

The P/B of BDX is 2.10. This compares price with reported book value per share.

What is the ROE of BDX?

The ROE (Return on Equity) of BDX is 6.61%. This relates the reported net result to shareholders' equity.

What is the dividend yield of BDX?

The dividend yield of BDX is 2.22%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of BDX?

The market capitalization of BDX is US$ 51.4 B.

What sector is BDX in?

BDX operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.